Nigel Keen chairs the Oxford AHSN Board. He is also Chairman of Syncona Partners, a company funded by The Wellcome Trust which was founded in 2012 and operates as an evergreen investment company, taking an active role in identifying, supporting and developing technologies with the potential significantly to impact the healthcare market of the future. He is also Chairman of Oxford University Innovation.
His career has encompassed venture capital, industry and banking. He has a degree in engineering from Cambridge University, is a Fellow of the Institute of Chartered Accountants, a Fellow of the Institute of Engineering and Technology and has been involved in the formation and development of high technology businesses for more than thirty years. He is also the Chairman of the AIM listed company, Deltex Medical.